ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Transcatheter

October 20, 2023
To create a benchmark for the use of TAVR for aortic stenosis treatment in low-risk patients, this study evaluated outcomes of similar patients undergoing SAVR. The STS database was used to isolate low-risk SAVR patients from 2011–2019.
October 13, 2023
As a part of the 2023 Australian Thoracic Aortic Symposium, Dr. Martin Misfeld presented on minimally invasive segmental artery coil embolization prior to cardiac surgery.
October 12, 2023
Transcatheter pulmonary valve replacement (tPVR) is a key therapy in RVOT pathologies but is associated with long term risks such as infective endocarditis (IE). In fact, some reports claim a higher IE risk compared to surgical pulmonary valve replacement.
September 26, 2023
This video demonstrates the authors’ step-by-step method for transaxillary TAVI.
September 21, 2023
This excellent review summarizes the existing evidence for use of balloon pulmonary angioplasty (BPA) based on the 2022 European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines and discusses the safety, efficacy, and its current role in relation to the more established pulmonary endarterectomy (PEA) and existing best medic
September 12, 2023
Survivors of Acute Stanford B (DeBakey III) in Holland: a patient-cantered follow-up indicating that the treatment strategy did not influence quality of life.
August 30, 2023
While much research is ongoing regarding the safety of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) after prior coronary artery bypass (CABG), there is limited data on morbidity outcomes and discharge locations among these two procedures.
August 24, 2023
During some transcatheter aortic valve implant (TAVI) procedures, complications require conversion to emergency open heart surgery (E-OHS). This study evaluated early and midterm outcomes in a large center over fifteen years. Patients were grouped by surgical risk and the study time was divided into three five-year periods.
July 27, 2023
In forty-eight consecutive patients undergoing explants of transcatheter aortic valve replacement (TAVR) at a single center between 2011 and 2021, at a median of 2.3 years after TAVR, the most common indications for surgery were nonstructural valve dysfunction (patient-prosthesis mismatch or paravalvular leak) in 35 percent, structural valve deterior
June 29, 2023
Recently, a minimal approach to transcatheter valve replacement using only local anesthesia has been used to promote a faster procedure and recovery time. With this lack of general anesthesia, however, comes more anxiety and the possibility of pain for patients.

Pages